Bioventix

Bioventix EBIT Margin

The EBIT Margin (Operating Margin) of Bioventix (BVXP.L) as of Nov 4, 2026 is 75.04 %. In the previous year, EBIT Margin (Operating Margin) was 75.51 % — a change of -0.63% (lower).

EBIT Margin

75.04 %

YoY

-0.63%

Last updated:

EBIT Margin (Operating Margin) of Bioventix is 2026 75.04 % . EBIT Margin (Operating Margin) of Bioventix was 2025 75.51 % . It decreases by -0.63% lower compared to the previous year.

For Bioventix, the operating (EBIT) margin of 75.0% is down versus 79.1% a few years ago.

The Bioventix EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2019
75.68 GBP
Jan 1, 2020
77.18 GBP
Jan 1, 2021
73.99 GBP
Jan 1, 2022
79.13 GBP
Jan 1, 2023
78.38 GBP
Jan 1, 2024
77.88 GBP
Jan 1, 2025
75.51 GBP
Jan 1, 2026
75.04 GBP
The Bioventix EBIT Margin history
YEAREBIT MarginYoY
75.04 %-0.63%
75.51 %-3.05%
77.88 %-0.63%
78.38 %-0.95%
79.13 %+6.95%
73.99 %-4.13%
77.18 %+1.98%
75.68 %-4.08%
78.90 %+0.11%
78.81 %+5.29%
74.85 %+4.71%
71.48 %+6.57%
67.08 %+9,933.56%
0.67 %+6.62%
0.63 %+14.63%
0.55 %+10.81%
0.49 %-16.88%
0.59 %+52.29%
0.39 %-334.00%
-0.17 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Bioventix Stock analysis

What does Bioventix do? Bioventix PLC is a well-known British provider of high-quality antibodies and innovative diagnostic products. The company has been operating in the industry for over 20 years. They specialize in producing antibodies that are specific to certain biomarkers and proteins with high precision and reproducibility. Bioventix PLC has a unique business model that allows them to maintain a high level of control over their supply chain and build strong relationships with their customers. They not only produce antibodies themselves but also sell licenses for their patents and technologies. The company also has its own research and development department that constantly works on improving existing products and developing new diagnostic products. Their diversification into different business areas, such as food and environmental analytics, has contributed to their growth and success so far. Overall, Bioventix PLC is an innovative and growing company that offers a wide range of high-quality and innovative products. Bioventix is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bioventix stock

EBIT Margin (Operating Margin) of Bioventix is 75.04 % in 2026.

EBIT Margin (Operating Margin) of Bioventix changed from 75.51 % to 75.04 %, representing a -0.63% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Bioventix since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Bioventix with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Bioventix

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Bioventix